Nature Biotechnology 24, 351 - 357 (2006)
Published online: 26 February 2006; | doi:10.1038/nbt1197
CD30 is a survival factor and a biomarker for transformed human pluripotent stem cellsDaniella Herszfeld, Ernst Wolvetang, Emma Langton-Bunker, Tung-Liang Chung, Adam A Filipczyk, Souheir Houssami, Pegah Jamshidi, Karen Koh, Andrew L Laslett, Anna Michalska, Linh Nguyen, Benjamin E Reubinoff, Irene Tellis, Jonathan M Auerbach, Carol J Ording, Leendert H J Looijenga
& Martin F Pera Supplementary Fig. 1 (pdf 1M)
Immunostaining of diploid ES or EC cells with antibodies to CD30. Supplementary Fig. 2 (pdf 308K)
Southern analysis of CD30 gene and PCR analysis of a repeat region in its promoter in normal and GCT DNA and EC cell lines. Supplementary Fig. 3 (pdf 28K)
Differentiation of diploid or karyotypically abnormal hESC in vitro. Supplementary Fig. 4 (pdf 1M)
Differentiation of diploid or karyotypically abnormal ES or EC cells in vivo. Supplementary Fig. 5 (pdf 196K)
Semiquantitative RT-PCR analysis of the expression of CD30 and CD30 variant in control and BMP-4 treated hESC. Supplementary Table 1 (pdf 44K)
Karyotype analysis of ES cell lines grown under different conditions.
| 
